TFCI Gains Attention as JhunjhunwalaPartnered Fund Acquires Stake MD Shares Business Outlook Crude Oil Above 100 Could Trigger Earnings Downgrade Cycle SMC Global CEO Indicates Jim Cramer Focus on Future Upside Not Past Gains for AI Stock Selection China AI Systems Response to Japanese Officials Condolences Raises Diplomacy Questions Eli Lillys Retatrutide Shows Strong Phase 3 Results CNBC Reports International Students Face Growing Hurdles in US Job Market Undermining American Dream NWPX Q1 2026 Earnings Strong Earnings Beat Drives Stock Higher WSFS Financial Q1 2026 Earnings EPS Surpasses Estimates by 122 Stock Unchanged RNST Q1 2026 Earnings EPS Surpasses Expectations Amid Challenging Banking Environment Perella Weinberg Partners Q1 2026 Earnings EPS Misses Estimates as Advisory Revenue Remains Undisclosed OTTR Q1 2026 Earnings Earnings Beat Estimates as EPS Surges 1986 Above Consensus PRGS Q1 2026 Earnings Modest EPS Beat Amidst Solid Operational Performance Baker Hughes BKR Faces Sharp Selloff Support Levels Under Pressure Entegris Inc ENTG Gains 296 as Semiconductor Materials Demand Holds Steady Air Products and Chemicals APD Holds Near Key Levels After Slight Uptick Tenon Medical TNON MicroCap Stock Holds Steady Near Key Support Levels Arqit Quantum Warrants ARQQW Slide 11 as Price Holds at 007 Support April Jobs Report Preview Labor Market Cooling But Stable Economists Suggest Ferrovial Q4 2025 Earnings EPS Beats Estimates Amidst Limited Revenue Disclosure Nurix Therapeutics NRIX Rallies 230 as Buyers Test Resistance Near 1867 AMPH Q1 2026 Earnings EPS Misses Estimates by 416 as Stock Edges Higher UZD Q1 2026 Earnings Significant EPS Beat Drives Stock Uptick NexPoint Real Estate Finance Inc Q1 2026 Earnings EPS Surpasses Estimates by 129 Stock Declines ROIV Q1 2026 Earnings WiderThanExpected Loss Amid PreCommercial Phase Five Point Holdings Q1 2026 Earnings Narrowing Loss Amid Quiet Quarter BBGI Q4 2025 Earnings Significant Loss Reported Shares Rally on Positives ASND Q1 2026 Earnings Wide EPS Miss as Ascendis Pharma Remains PreRevenue Stock Edges Higher